MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Women and PD: experienced changes in parkinson symptoms after menopause

    W. Kapelle, A. Oosterbaan, E. Stuart, B. Bloem, M. Meinders, B. Post (Nijmegen, Netherlands)

    Objective: This study aimed to gain insight into changes in parkinson (PD) symptoms experienced by women after menopause. Background: Although most people are diagnosed with…
  • 2023 International Congress

    Understanding caffeine consumption in Huntington’s Disease

    J. Adrissi, S. Brooker, A. Mcbride, D. Larson, E. Gausche, D. Bega (Los Angeles, USA)

    Objective: The purpose of this study is to better understand the amount of caffeine consumption in people with HD and the subjective motivations and consequences…
  • 2023 International Congress

    Subthalamic Nucleus Deep Brain Stimulation in GBA-associated Parkinson Disease: Cognitive and motor follow-up of two clinical cases

    I. Carvalho, D. Damas, I. Cunha, S. Caldeira, P. Monteiro, R. Pereira, F. Moreira (Coimbra, Portugal)

    Objective: To report the long-term motor and cognitive outcome of two patients with GBA-associated Parkinson’s disease (PD) who underwent STN-DBS surgery. Background: Recent studies suggest…
  • 2023 International Congress

    Pisa syndrome and botulinum toxin injection in paraspinal muscles ipsilateral to the bending side: a pilot study

    V. Cenacchi, TMI. Lombardo, G. Bellavita, M. Catalan, V. Tommasini, M. Liccari, G. Mazzon, L. Antonutti, P. Manganotti (Trieste, Italy)

    Objective: Our study aimed at evaluating the clinical and electromyographical effects of botulinum toxin (BoNT) injections in patients with Pisa syndrome (PS) in Parkinson’s disease…
  • 2023 International Congress

    Linking volume of tissue activated to neural oscillations in deep brain stimulation

    A. Kutuzova, C. Graef, B. Lonergan, Y. Tai, S. Haar (London, United Kingdom)

    Objective: Exploring the effect of deep brain stimulation (DBS) settings on neural oscillations in Parkinson’s disease (PD) patients with subthalamic nucleus (STN) DBS and their…
  • 2023 International Congress

    Early versus late levodopa administration in Parkinson’s disease: Comparative study

    A. Akid, I. Kacem, A. Guedi, Y. Abida, S. Mrabet, A. Souissi, A. Gharbi, A. Nasri, R. Gouider (Tunis, Tunisia)

    Objective: To evaluate levodopa-sparing strategy in terms of motor decline and complications. Background: Levodopa remains the gold standard for treatment of Parkinson’s disease(PD), as it…
  • 2023 International Congress

    Melatonin for huntington disease (HD) gene carriers with HD-related sleep disturbance – a pilot study

    J. Patino, S. Zadegan, N. Rocha, N. Karagas, W. Tanigaki, B. Duncan, E. Furr Stimming (Houston, USA)

    Objective: To evaluate the efficacy of exogenous melatonin in improving sleep quality in Huntington disease (HD) gene carriers. Background: Various sleep disorders have been identified…
  • 2023 International Congress

    The Quebec Parkinson Network (QPN): Interdisciplinary Collaboration in Parkinson’s Disease and Related Disorders Research.

    M. Blais, S. Bogard, C. Degroot, N. Dupré, E. Fon (Quebec City, Canada)

    Objective: By creating a participant registry, gathering information on participants, and ensuring appropriate data exchange with research groups, the QPN's primary goal is to increase…
  • 2023 International Congress

    Improvements in Parkinson’s disease motor complications after treatment with opicapone: results from the OPTI-ON study

    C. Kilbane, R. Drake, O. Klepitskaya, M. Serbin, E. Jen, S. Rattana, J. Trotter, G. Liang (Cleveland, USA)

    Objective: To describe motor complications as measured by the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) Part IV in participants from the Opicapone Treatment…
  • 2023 International Congress

    Rapidly progressive dementia – catatonia – myoclonus in 80 years old patient: An unusual case

    DAN. Rebolledo Garcia, ART. Cadena Fernandez, ANA. Michel Chavez, JUA. Calderon Martinez, HOR. Senties Madrid, GRI. Romero Sanchez (Mexico City, Mexico)

    Objective: Objective:Sporadic Creutzfeldt-Jakob Disease (sCJD) will be challenging to differentiate from other diseases, like NMDA autoimmune encephalitis (AE). The classic rapidly progressive dementia phenotype that…
  • « Previous Page
  • 1
  • …
  • 90
  • 91
  • 92
  • 93
  • 94
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley